NWK Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-72,958
Closed -$6.96M 68
2025
Q4
$6.96M Sell
72,958
-241
-0.3% -$23.6K 2.42% 18
2025
Q3
$7.15M Sell
73,199
-228
-0.3% -$23.6K 2.43% 20
2025
Q2
$7.89M Sell
73,427
-611
-0.8% -$61.8K 2.77% 18
2025
Q1
$7.47M Sell
74,038
-1,686
-2% -$170K 3.42% 12
2024
Q4
$6.76M Buy
75,724
+1,571
+2% +$138K 2.61% 17
2024
Q3
$6.21M Sell
74,153
-718
-1% -$56.6K 2.53% 18
2024
Q2
$5.77M Buy
74,871
+185
+0.2% +$13.5K 2.42% 17
2024
Q1
$5.12M Buy
74,686
+1,738
+2% +$112K 2.4% 17
2023
Q4
$4.22M Buy
+72,948
New +$3.89M 2.17% 20

Other funds holding BSX

NWK Group's BSX Position: Q1 2026 in Review

NWK Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 72,958 shares — an estimated $6.96M sold.

NWK Group first reported a position in BSX in Q4 2023 and held it in 9 quarters. The position peaked at $7.89M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • NWK Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • NWK Group sold 72,958 Boston Scientific shares in Q1 2026, an estimated $6.96M.
  • NWK Group first reported a position in Boston Scientific in Q4 2023 and held it in 9 quarters.
  • NWK Group's Boston Scientific position peaked at $7.89M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on NWK Group's 13F filing for Q1 2026, filed 7 May 2026.